Project 1: Human and Non-human Primate Influenza B-cell Repertoires
- Institution
- BOSTON CHILDREN'S HOSPITAL, MA
- Principal investigator
- Michael Anthony Moody
- Funding
- $710K
- Duration
- 2025–2028
Moonbase score
Still being scored
Abstract
Abstract -- Project 1 Project 1 will study the updating of imprinted responses to influenza infection and vaccination that occurs during subsequent influenza vaccination. The hypothesis is that imprinting of B cell memory to influenza by initial infection will induce more neutralization but less breadth directed at heterologous strains, while initial imprinting by influenza vaccine will provide greater breadth but less neutralizing activity. Project 1 will test this hypothesis in a series of experiments in humans and rhesus macaques, in which we will probe the B cell repertoires in response to combinations of influenza infection and vaccination. Project 1 will perform experiments in non-human primates where the exposure to influenza antigens can be tightly controlled and will collect samples from humans of all ages receiving influenza vaccination to quantify responses in a “real world” setting. For all aims, the goals will be to 1) quantify the effect of exposure to different influenza subtypes by infection and vaccination, 2) quantify recall upon antigenic challenge by vaccination or infection and 3) quantify the epitope specific response to influenza. We will pursue these goals using serology, Nojima cultures, and monoclonal antibody (mAb) isolation, for epitope mapping and structural studies, in collaboration with Project 4.
LOADING MOONBASE SCORE
Questions for BOSTON CHILDREN'S HOSPITAL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Duke UniversityNot yet scored
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum
Michael Anthony Moody · $2.3M · 2024–2029
- NIH · Boston Children'S Hospital67
A 90 day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children with Short Bowel Syndrome who are Dependent on Parenteral Nutrition
Mark Puder · $365K · 2021–2028
- NIH · Boston Children'S Hospital64
Motion and Distortion Robust Diffusion Weighted Imaging Sequences for Pediatric Patients
Onur Afacan · $398K · 2022–2027